Advertisement

Qiagen N.V. QGEN

Set alert

Price alert · QGEN

All alert types
50.22 USD -0.12 -0.24%

At close · Oct 30

50.22 0.00 0.00%

After hours · Oct 30, 5:54 PM ET

Bid
50.20 × 1,500
Ask
50.21 × 3,500
50.08 Day range 50.39
32.63 52-week range 55.66
YTD
+11.67%
1 year
+8.40%
Open
50.35
Prev close
50.34
Mkt cap
10.37B
Vol
4.17M
Avg vol
3.55M
EPS
1.97
P/E
25.49
Div yield
0.70%
More statistics
Low
50.08
High
50.39
Forward P/E
19.21
Beta
0.61
Short ratio
3.34
Inst. own
79.42%
Dividend
0.35
Ex-div date
Jul 6, 2026
Earnings
Nov 4, 2026
50-d avg
45.00
200-d avg
42.58
1y target
49.02

5D chart

Chart tools
Interval

Events in this range
  • Oct 26, 2026Rating: Citigroup · Neutral → Neutral
  • Oct 28, 2026Downgrade: Barclays · Overweight → Equal-Weight
Signals (71)
NameTimeAgo
MACD: Buy SignalOct 30, 11:35 AM1 day ago
SMA: BearishOct 30, 9:35 AM1 day ago
MACD: Sell SignalOct 30, 9:30 AM1 day ago
SMA: BullishOct 29, 3:15 PM2 days ago
SMA: BearishOct 29, 3:10 PM2 days ago
MACD: Buy SignalOct 29, 2:25 PM2 days ago
SMA: BullishOct 29, 2:10 PM2 days ago
SMA: BullishOct 29, 2:10 PM2 days ago
SMA: BearishOct 29, 1:50 PM2 days ago
SMA: BearishOct 29, 1:50 PM2 days ago
MACD: Sell SignalOct 29, 1:50 PM2 days ago
MACD: Buy SignalOct 29, 1:40 PM2 days ago
SMA: BullishOct 29, 1:35 PM2 days ago
SMA: BullishOct 29, 1:35 PM2 days ago
SMA: BearishOct 29, 12:45 PM2 days ago
SMA: BullishOct 29, 12:40 PM2 days ago
SMA: BullishOct 29, 12:40 PM2 days ago
SMA: BearishOct 29, 12:35 PM2 days ago
MACD: Sell SignalOct 29, 11:55 AM2 days ago
SMA: BearishOct 29, 11:50 AM2 days ago
SMA: BullishOct 29, 11:45 AM2 days ago
SMA: BullishOct 29, 10:20 AM2 days ago
MACD: Buy SignalOct 29, 10:20 AM2 days ago
SMA: BearishOct 29, 9:30 AM2 days ago
SMA: BearishOct 29, 9:30 AM2 days ago
MACD: Sell SignalOct 29, 9:30 AM2 days ago
SMA: BearishOct 28, 2:55 PM3 days ago
MACD: Buy SignalOct 28, 2:50 PM3 days ago
SMA: BullishOct 28, 2:45 PM3 days ago
SMA: BullishOct 28, 2:45 PM3 days ago
SMA: BearishOct 28, 2:30 PM3 days ago
MACD: Sell SignalOct 28, 1:00 PM3 days ago
SMA: BullishOct 28, 12:00 PM3 days ago
MACD: Buy SignalOct 28, 12:00 PM3 days ago
SMA: BearishOct 28, 11:30 AM3 days ago
SMA: BearishOct 28, 11:30 AM3 days ago
MACD: Sell SignalOct 28, 11:00 AM3 days ago
MACD: Buy SignalOct 28, 9:45 AM3 days ago
RSI: OversoldOct 27, 3:55 PM4 days ago
MACD: Sell SignalOct 27, 3:50 PM4 days ago
SMA: BearishOct 27, 3:15 PM4 days ago
MACD: Buy SignalOct 27, 3:10 PM4 days ago
RSI: OversoldOct 27, 2:55 PM4 days ago
RSI: OversoldOct 27, 2:15 PM4 days ago
MACD: Sell SignalOct 27, 2:00 PM4 days ago
SMA: BearishOct 27, 1:55 PM4 days ago
MACD: Buy SignalOct 27, 12:45 PM4 days ago
SMA: BullishOct 27, 12:40 PM4 days ago
SMA: BearishOct 27, 12:35 PM4 days ago
SMA: BullishOct 27, 12:30 PM4 days ago
RSI: OversoldOct 27, 12:15 PM4 days ago
RSI: OversoldOct 27, 11:55 AM4 days ago
MACD: Sell SignalOct 27, 10:55 AM4 days ago
SMA: BearishOct 27, 10:40 AM4 days ago
SMA: BullishOct 27, 10:00 AM4 days ago
SMA: BearishOct 27, 9:55 AM4 days ago
SMA: BullishOct 27, 9:50 AM4 days ago
SMA: BullishOct 27, 9:50 AM4 days ago
SMA: BearishOct 27, 9:30 AM4 days ago
SMA: BullishOct 26, 3:50 PM5 days ago
MACD: Buy SignalOct 26, 3:50 PM5 days ago
MACD: Sell SignalOct 26, 3:45 PM5 days ago
MACD: Buy SignalOct 26, 3:40 PM5 days ago
MACD: Sell SignalOct 26, 3:25 PM5 days ago
SMA: BearishOct 26, 3:20 PM5 days ago
RSI: OversoldOct 26, 3:20 PM5 days ago
MACD: Buy SignalOct 26, 3:00 PM5 days ago
SMA: BullishOct 26, 2:50 PM5 days ago
MACD: Sell SignalOct 26, 1:50 PM5 days ago
RSI: OversoldOct 26, 1:50 PM5 days ago
MACD: Buy SignalOct 26, 1:05 PM5 days ago

Key statistics

Market cap
10.37B
Enterprise value
11.26B
Trailing P/E
25.49
Forward P/E
19.21
PEG ratio
1.34
Price / sales
4.94
Price / book
3.09
EPS (TTM)
1.97
Beta
0.61
Dividend yield
0.70%
Payout ratio
17.79%
Profit margin
19.49%
Revenue (TTM)
2.10B
Revenue growth
0.30%
Free cash flow
372.86M
Total cash
793.50M
Total debt
1.65B
Return on equity
11.93%
Shares outstanding
206.50M
Short % of float
3.95%
50-day average
45.00
200-day average
42.58

Analyst view

Consensus: hold

Hold
Price target (mean) 49.02 -2.4% downside
Target (low)
40.00
Target (mean)
49.02
Target (high)
53.00
Ratings (0m) 12 1 buy · 11 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold11
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate 0.62725.

Earnings history

Financials — quick view

All financials
QGEN Revenue — quarterly 535.04M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
QGEN Net income — quarterly 103.40M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
QGEN EPS — quarterly 0.50
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

QGEN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 20260.627———
Aug 5, 2026Jun 30, 20260.5980.62+0.02+3.68%
May 6, 2026Mar 31, 20260.5420.540.00-0.37%
Feb 4, 2026Dec 31, 20250.610.62+0.01+1.64%
Nov 4, 2025Sep 30, 20250.610.64+0.03+4.92%
Aug 5, 2025Jun 30, 20250.600.600.000.00%

Upgrades / downgrades

QGEN analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026BarclaysdownOverweightEqual-Weight
Oct 26, 2026CitigroupmainNeutralNeutral
Oct 22, 2026JP MorgandownOverweightNeutral
Oct 22, 2026BairdmainOutperformOutperform
Oct 14, 2026JP MorganmainOverweightOverweight
Oct 6, 2026BarclaysupEqual-WeightOverweight

About Qiagen N.V.

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Sector
Healthcare
Industry
Diagnostics & Research
Country
Netherlands
Website
qiagen.com

News

Your note

Sign in to keep a note on QGEN — it syncs with the Stock Master app.

Institution ownership

QGEN institution ownership
Holder% heldSharesValueReported
Wellington Management Group, LLP6.02%12,406,763622.94MJun 29, 2026
Price (T.Rowe) Associates Inc5.51%11,354,379570.10MJun 29, 2026
Principal Financial Group, Inc.3.23%6,648,681333.83MJun 29, 2026
Vanguard Capital Management LLC3.01%6,209,904311.80MJun 29, 2026
Blackrock Inc.2.87%5,905,678296.52MJun 29, 2026
Morgan Stanley2.45%5,042,391253.18MJun 29, 2026

Fund ownership

QGEN fund ownership
Holder% heldSharesValueReported
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund2.93%6,045,368303.54MJul 30, 2026
TR PRICE-Price (T.Rowe) International Growth Equity Trust2.61%5,376,369269.95MJun 29, 2026
MFS Series Trust XVII-MFS International Equity Fund2.12%4,363,511219.09MJun 29, 2026
T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Stock Fd.1.87%3,845,943193.10MJul 30, 2026
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund1.47%3,037,846152.53MJul 30, 2026
MFS SERIES TRUST I-MFS Research International Fund1.23%2,526,121126.84MAug 30, 2026
Advertisement